This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| health economics | |
|---|---|
| Name | Health economics |
| Discipline | Economics, Medicine, Public policy |
health economics is an interdisciplinary field examining allocation, distribution, and utilization of resources for health and health care. It draws on methods from Adam Smith-influenced classical analysis, John Maynard Keynes-era macroeconomics, and microeconomic theory developed by Paul Samuelson and Kenneth Arrow. Scholars engage with institutions such as the World Health Organization, World Bank, and Organisation for Economic Co-operation and Development to inform policy decisions in settings shaped by actors like the Bill & Melinda Gates Foundation and national agencies including the National Health Service and Centers for Disease Control and Prevention.
The field spans comparative studies of systems such as the National Health Service (United Kingdom), the Medicare (United States) program, and the Bismarck model historically linked to Otto von Bismarck’s reforms, while interacting with global initiatives led by the United Nations and Gavi, the Vaccine Alliance. Researchers analyze financing arrangements used in countries like Germany, France, Japan, and Brazil and institutions such as the International Monetary Fund that influence fiscal space for health. Influential economists including Amartya Sen, Joseph Stiglitz, and Michael Grossman have shaped normative and positive questions about welfare, equity, and human capital as applied to health. Empirical work often uses datasets from organizations such as the Organisation for Economic Co-operation and Development and national statistical agencies like the Office for National Statistics.
Methods include cost-effectiveness analysis developed alongside clinical trial practice at centers like Johns Hopkins University and Harvard University, cost–utility analysis that utilizes quality-adjusted life years popularized after work by Alan Williams and Richard Zeckhauser, and cost–benefit analysis rooted in welfare economics of Vilfredo Pareto and Arthur Pigou. Decision analytic modeling uses techniques from operations research advanced at institutions like the Massachusetts Institute of Technology and RAND Corporation. Comparative effectiveness research often references regulatory frameworks of agencies such as the Food and Drug Administration and National Institute for Health and Care Excellence. Methods draw on econometric approaches pioneered by James Heckman and Angus Deaton for causal inference and on trial design traditions from Frederick Mosteller and Donald Rubin.
Financing mechanisms range from social insurance systems influenced by legislation such as the Social Security Act to private insurance markets regulated by statutes including the Affordable Care Act. Models compare single-payer systems like those in Canada and mixed payer arrangements found in Australia and Switzerland. Risk pooling and moral hazard questions reference foundational work by Kenneth Arrow and market analyses in contexts like the New York Stock Exchange where health sector firms are traded. Public payers such as Medicaid and international funders including the Global Fund shape service delivery, while reinsurers and organizations like Aetna and Blue Cross Blue Shield participate in market operations.
Analyses examine system performance metrics used by the Organisation for Economic Co-operation and Development and policy decisions shaped by bodies such as the European Commission and national ministries like the Ministry of Health (Brazil). Comparative health policy draws on case studies from the Affordable Care Act implementation, reforms in Germany and Taiwan, and universal coverage efforts in Thailand. Research engages with governance frameworks seen in the World Bank’s health sector projects and program evaluation traditions at centers like the Brookings Institution and Kaiser Family Foundation.
Demand-side research models consumer behavior informed by utility theory from Lionel Robbins and market responses to information asymmetry as theorized by George Akerlof; classic examples include analysis of principal–agent relations in physician practice linked to studies in Harvard Medical School settings. Supply-side studies consider provider markets dominated by hospitals such as Mayo Clinic and corporate entities like UnitedHealth Group and effects of entry and consolidation traced through antitrust cases at the United States Department of Justice. Pharmaceutical markets reference patent law cases adjudicated by the United States Supreme Court and industry dynamics involving firms like Pfizer and Roche.
Microcosting and gross-cost approaches use accounting standards influenced by organizations such as the International Accounting Standards Board and budgeting techniques applied in ministries like the Ministry of Finance (India). Priority-setting frameworks reference work by Tarun Bhatnagar and international guidelines from the World Health Organization on essential packages. Allocation debates engage health technology assessment agencies such as National Institute for Health and Care Excellence and budget impact analyses commissioned by national payers like Centers for Medicare & Medicaid Services.
Equity analysis builds on theories of welfare and justice articulated by John Rawls and Amartya Sen and operationalizes measures used in studies by UNICEF and the World Bank. Ethical considerations intersect with clinical research governance governed by documents like the Declaration of Helsinki and institutional review boards at universities such as Stanford University. Outcome measurement employs patient-reported outcome instruments developed in collaborations with hospitals like Cleveland Clinic and multinational surveys administered by the European Centre for Disease Prevention and Control.